Robotic versus laparoscopic total mesorectal excision for mid-low rectal cancer with difficult anatomical conditions

被引:5
|
作者
Pan, Jiahao [1 ]
Wang, Bo [1 ]
Feng, Zhen [1 ]
Sun, Zhiwei [1 ]
Xia, Cong [1 ]
Zhang, Qianshi [1 ,2 ]
Ren, Shuangyi [1 ,2 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, Dalian 116023, Liaoning, Peoples R China
[2] Dalian Med Univ, Affiliated Hosp 2, Dept Gastrointestinal Surg, 467 Zhongshan Rd, Dalian 116023, Liaoning, Peoples R China
关键词
Minimally invasive surgical procedure; Rectal cancer; Robot surgery; SHORT-TERM OUTCOMES; OPEN SURGERY; REINFORCING SUTURES; ANTERIOR RESECTION; ONCOLOGIC OUTCOMES; COLON-CANCER; SURVIVAL; RISK;
D O I
10.1016/j.asjsur.2022.01.026
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Laparoscopic total mesorectal excision (L-TME) is difficult to perform because of its technical shortcomings in cases of difficult anatomical condition. In such situations, robotic TME (R-TME) tends to be the procedure of choice. This study aimed to compare R-TME and L-TME treatments for mid-low rectal cancer in patients with difficult anatomical conditions. Methods: This retrospective single-center study examined data from 01/2019 to 02/2021 of mid-low rectal cancer patients with difficult anatomical conditions. Perioperative data, short-term outcomes, and 2-year oncologic outcomes were compared between groups. Results: The 106 patients were divided into R-TME (n = 56) and L-TME (n = 50). R-TME was associated with a lower diverting ileostomy rate (28.6% vs 50.0%, P = 0.005). R-TME involved a longer operation time (180 min vs 147.5 min, P < 0.001) but a similar procedure time (147.5 min vs 143.5 min, P = 0.110). More patients treated with R-TME experienced mild postoperative pain (33.9% vs 12.0%, P = 0.015) at a much higher cost ([$13740.8 +/- 2038.13] vs [$9579.97 +/- 2404.22], P < 0.001). The 2-year overall survival and disease-free survival rates were similar between the groups. Conclusion: R-TME, when performed by an experienced surgeon, can reduce the diverting ileostomy rate and relieve postoperative pain without a longer procedure time but at a higher cost. Larger trials of difficult patients with extended follow-up times are expected. (c) 2022 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/).
引用
收藏
页码:2725 / 2732
页数:8
相关论文
共 50 条
  • [1] Total mesorectal excision for mid and low rectal cancer: laparoscopic vs robotic surgery
    Francesco Feroci
    Andrea Vannucchi
    Paolo Pietro Bianchi
    Stefano Cantafio
    Alessia Garzi
    Giampaolo Formisano
    Marco Scatizzi
    [J]. World Journal of Gastroenterology, 2016, (13) : 3602 - 3610
  • [2] Total mesorectal excision for mid and low rectal cancer: Laparoscopic vs robotic surgery
    Feroci, Francesco
    Vannucchi, Andrea
    Bianchi, Paolo Pietro
    Cantafio, Stefano
    Garzi, Alessia
    Formisano, Giampaolo
    Scatizzi, Marco
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (13) : 3602 - 3610
  • [3] Predicting Difficult Laparoscopic Total Mesorectal Excision for Locally-advanced Mid-low Rectal Cancer: The EuMaRCS Score Validation
    de'Angelis, Nicola
    Martinez-Perez, Aleix
    Vitali, Giulio Cesare
    Pigneur, Frederic
    Luciani, Alain
    Brunetti, Francesco
    Kraft, Miquel
    Marti-Martinez, Eva
    Moroni, Paolo
    Espin, Eloy
    Ris, Frederic
    Pucciarelli, Salvatore
    [J]. ANTICANCER RESEARCH, 2020, 40 (04) : 2079 - 2087
  • [4] Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy
    Lim, Dae Ro
    Bae, Sung Uk
    Hur, Hyuk
    Min, Byung Soh
    Baik, Seung Hyuk
    Lee, Kang Young
    Kim, Nam Kyu
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (04): : 1728 - 1737
  • [5] Laparoscopic total mesorectal excision with urogenital fascia preservation for mid-low rectal cancer: Anatomical basis and clinical effect - Experimental research
    Liu, Hailong
    Chang, Yi
    Li, Ajian
    Wang, Wenchao
    Lv, Liang
    Peng, Jian
    Pan, Zhihui
    Jiang, Huihong
    Lin, Moubin
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2022, 99
  • [6] Transanal Total Mesorectal Excision Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
    Yuksel, Bulent Cavit
    [J]. DISEASES OF THE COLON & RECTUM, 2021, 64 (06) : E383 - E383
  • [7] Sphincter-Saving Robotic Total Mesorectal Excision Provides Better Mesorectal Specimen and Good Oncological Local Control Compared with Laparoscopic Total Mesorectal Excision in Male Patients with Mid-Low Rectal Cancer
    Aliyev, Vusal
    Bakir, Baris
    Goksel, Suha
    Guven, Koray
    Asoglu, Oktar
    [J]. SURGICAL TECHNOLOGY INTERNATIONAL-INTERNATIONAL DEVELOPMENTS IN SURGERY AND SURGICAL RESEARCH, 2021, 38
  • [8] Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer
    Zeng, Ziwei
    Liu, Zhihang
    Luo, Shuangling
    Liang, Zhenxing
    Huang, Liang
    Ruan, Lei
    Chen, Junji
    Jie, Haiqing
    Liang, Wenfeng
    Liu, Huashan
    Kang, Liang
    [J]. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2022, 36 (06): : 3902 - 3910
  • [9] Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer
    Ziwei Zeng
    Zhihang Liu
    Shuangling Luo
    Zhenxing Liang
    Liang Huang
    Lei Ruan
    Junji Chen
    Haiqing Jie
    Wenfeng Liang
    Huashan Liu
    Liang Kang
    [J]. Surgical Endoscopy, 2022, 36 : 3902 - 3910
  • [10] Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis
    Chi, Zhang Yi
    Gang, Ou
    Li, Feng Xiao
    Ya, Lu
    Zhijun, Zhou
    Gang, Du Yong
    Dan, Ran
    Xin, Liu
    Yang, Liu
    Peng, Zhang
    Yi, Luo
    Dong, Lin
    De Chun, Zhang
    [J]. MEDICINE, 2024, 103 (04) : E36859